Torrent Pharma has announced a board meeting to approve a major strategic move: acquiring a 46.39% stake in J.B. Chemicals & Pharmaceuticals (JB Pharma) for INR 11,917 Cr, followed by an open offer of up to 26% at INR 1,639.18 per share, and potential purchase of up to 2.8% from employees. Post-acquisition, Torrent plans to merge JB Pharma into itself with a share exchange ratio of 51 Torrent shares for every 100 JB Pharma shares. This deal boosts Torrent’s Indian Pharma Market presence, expands its portfolio with JB Pharma’s strong chronic & hypertension brands, and adds a promising CDMO platform, creating a diversified, growth-oriented healthcare powerhouse.